The publication, titled Poly-L-Ornithine coated plant scaffolds support motor recovery in rats after traumatic spinal cord injury, counts Spiderwort Biotechnologies' Chief Executive Officer, Dr.

The publication, titled Poly-L-Ornithine coated plant scaffolds support motor recovery in rats after traumatic spinal cord injury, counts Spiderwort Biotechnologies' Chief Executive Officer, Dr.

This winter, medical experts guide you through the latest diagnostic standards, the non-deficiency causes of fatigue, and the practical steps you can take ...

BOSTON, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into ...

Investing.com -- Praxis Precision Medicines (NASDAQ:PRAX) stock surged 25% after the company announced its EMBOLD study evaluating relutrigine was stopped early due to positive efficacy results. The ...

Having already claimed a win for the phase 2 study of its seizure drug, Praxis Precision Medicines is hoping fresh efficacy data will form the backbone of an approval application for the sodium ...

Praxis Precision Medicines shares shot skyward Friday after the company stopped an epilepsy study early due to strong effectiveness.

Praxis Precision Medicines Inc. (NASDAQ: PRAX) is one of the best 52-week high stocks to buy right now. Piper Sandler on December 5 reaffirmed its Overweight rating and $450 target on Praxis Precision ...

Saturday’s $200,000 Grade 2 Los Alamitos Futurity boasts a long and rich history. This year’s edition has drawn half a dozen ...

Praxis Precision Medicines has also announced a “successful” pre-NDA meeting with the FDA for its essential tremor drug candidate ulixacaltamide, for which an approval application is slated for early ...